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In an effort to understand the role of Distal-less 3 (Dlx3) in cutane-
ous biology and pathophysiology, we generated and characterized
a mouse model with epidermal ablation of Dlx3. K14cre;Dlx3Kin/f
mice exhibited epidermal hyperproliferation and abnormal differ-
entiation of keratinocytes. Results from subsequent analyses
revealed cutaneous inﬂammation that featured accumulation of
IL-17–producing CD4+ T, CD8+ T, and γδ T cells in the skin and lymph
nodes of K14cre;Dlx3Kin/f mice. The gene expression signature of
K14cre;Dlx3Kin/f skin shared features with lesional psoriatic skin,
and Dlx3 expression was markedly and selectively decreased in
psoriatic skin. Interestingly, cultured Dlx3 null keratinocytes trig-
gered cytokine production that is potentially linked to inﬂam-
matory responses in K14cre;Dlx3Kin/f mice. Thus, Dlx3 ablation in
epidermis is linked to altered epidermal differentiation, barrier de-
velopment, and IL-17–associated skin inﬂammation. This model
provides a platform that will allow the systematic exploration of
the contributions of keratinocytes to cutaneous inﬂammation.
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Skin functions as a barrier that protects the body from the ex-ternal environment and excessive water loss. Barrier function
is established through multistage differentiation of keratinocytes
in the epidermis. During this process, keratinocytes differentiate
from proliferative cells in the basal layer into ﬂattened corniﬁed
cells in the stratum corneum, associated with expression of dif-
ferentiation-speciﬁc proteins, many of which are encoded by
genes clustered in the epidermal differentiation complex (EDC).
Leukocytes in skin play a key role as sentinels, and crosstalk be-
tween keratinocytes and leukocytes is crucial for maintenance
of the skin homeostasis (1). When the epidermal barrier is dis-
rupted, keratinocytes produce cytokines and chemokines to re-
cruit leukocytes from blood into skin (2, 3).
Recent studies indicate that genetic mutations, particularly in
genes in the EDC, are linked to barrier dysfunction in three
common skin disorders: ichthyosis vulgaris, atopic dermatitis
(AD), and psoriasis (PS). The EDC encodes proteins including
ﬁlaggrin (Flg), loricrin (Lor), S100 proteins, late corniﬁed enve-
lope (LCE) proteins, and the small proline-rich (Sprr) proteins
(4). Loss-of-function mutations in the Flg gene have been iden-
tiﬁed as causative in ichthyosis vulgaris and AD (5, 6). Genome-
wide association studies also identiﬁed susceptibility variants
within the LCE gene cluster in PS (7, 8).
Although inﬂammatory skin disorders are often accompanied
by decreased barrier function, the role of keratinocyte dysfunc-
tion in disease causality is often unclear. Most notably, inﬂamed
skin generally exhibits abnormal keratinocyte differentiation, dis-
rupted barrier function, and/or immunocyte abnormalities (9–11).
Studying key genes that are active in immunologic functions as
well as epidermal homeostasis will provide insight into the in-
tricate regulatory networks involved in complex inﬂammatory
skin diseases.
Distal-less 3 (Dlx3) is a homeobox transcription factor involved
in terminal differentiation of keratinocytes (12). Misexpression of
Dlx3 in the basal layer results in decreased keratinocyte pro-
liferation and premature terminal differentiation (13). To study
the role of Dlx3 in the skin homeostasis, we generated conditional
epidermis-speciﬁc knockout K14cre;Dlx3Kin/f mice (14). In the
present study, we characterized the abnormal differentiation and
hyperproliferation of keratinocytes in the skin of K14cre;Dlx3Kin/f
mice, along with the development of IL-17–associated skin in-
ﬂammation distinguished by cytokine and chemokine up-regula-
tion and leukocyte inﬁltration that resembles a human skin
inﬂammatory disease.
Results
Epidermal-Speciﬁc Ablation of Dlx3 Results in Altered Barrier
Formation. K14cre;Dlx3Kin/f mice presented a gross phenotype
distinguished by persistent scaly skin (Fig. 1A). To assess barrier
function, we performed dye exclusion assays (15) at E17.5 and
found that WT embryos excluded dye, whereas K14cre;Dlx3Kin/f
embryos uniformly exhibited dye penetration into skin (Fig. 1B).
By E18.5, the K14cre;Dlx3Kin/f fetuses did not show obvious
percutaneous dye penetration, demonstrating delayed establish-
ment of the water barrier in developing skin. To further assess
barrier function-related features of K14cre;Dlx3Kin/f skin, we
analyzed E18.5 corniﬁed envelopes (CEs) using phase-contrast
microscopy. Compared with the WT CEs and consistent with
abnormal barrier function, mutant mice exhibited fragile CEs
(Fig. 1C, arrowheads) with a rigidly polygonal shape.
Mice Lacking Dlx3 in Epidermis Exhibit Abnormalities in Epidermal
Differentiation and Hyperplasia. To determine whether the
K14cre;Dlx3Kin/f mice exhibited impaired epidermal differentia-
tion, we compared the expression of Lor and Flg proteins in
epidermis via Western blot analysis. The K14cre;Dlx3Kin/f mice
exhibited diminished expression of Lor and Flg at P3 (Fig. 1D).
Claudins, which are key components of tight junctions (16), es-
pecially Claudin 7, also were decreased in P3 K14cre;Dlx3Kin/f
skin (Fig. 1D).
K6 and K16 are hyperproliferation-associated keratins that are
up-regulated in uninvolved and lesional psoriatic epidermis (2).
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Elevated proliferation was detected in the skin of K14cre;Dlx3Kin/f
mice by immunohistochemistry using anti-K6 and anti-proliferating
cell nuclear antigen (PCNA) antibodies (Fig. 1E) and conﬁrmed by
microarray analysis (Fig. 2A). The status of epidermal differentia-
tion in K14cre;Dlx3Kin/f mice also was assessed via gene expression
analysis of whole skin (Fig. 2A). Most prominently, Lce(s) genes,
which are frequently up-regulated during barrier dysfunction, were
induced in K14cre;Dlx3Kin/f skin (Fig. 2A). The signiﬁcant up-reg-
ulation of Sprr2h and Sprr2d in the K14cre;Dlx3Kin/f mice sug-
gested stimulation of a compensatory mechanism similar to that
reported previously (17). Expression of the differentiation-speciﬁc
markers Lor and Flg was assessed by qPCR analysis and immu-
nohistochemistry (for Flg), showing that although expression was
lower in mutant skin than in WT at P1, P3, and P5, expression of
these differentiation markers was signiﬁcantly up-regulated be-
ginning on P9 (Fig. 2B and Fig. S1). Altered expression of dif-
ferentiation and cell envelope proteins that are frequently up-
regulated during barrier dysfunction (Fig. 2A) are consistent with
sustained abnormalities in epidermal differentiation.
Other genes involved in barrier formation and function, in-
cluding peroxisome proliferator-activated receptor (PPAR) and
transglutaminase (Tgm), were down-regulated in K14cre;Dlx3Kin/f
mice (Fig. 2A). qPCR performed to validate Dlx3 ablation in the
K14cre;Dlx3Kin/f samples showed decreased expression of Dlx3
and hair-speciﬁc keratin 32 (K32), a Dlx3 target (14), in K14cre;
Dlx3Kin/f mice (Fig. S2).
Development of an Inﬂammatory Response in K14cre;Dlx3Kin/f Skin.
The skin of K14cre;Dlx3Kin/f mice demonstrated up-regulation of
genes encoding inﬂammatory mediators and antimicrobial pep-
tides (Fig. 2A). Progressively increased expression of S100a8 and
S100a9 was observed in K14cre;Dlx3Kin/f skin. Defensins, partic-
ularly β-defensin 3 (Defb3), also were signiﬁcantly up-regulated at
P20, and up-regulation of lipocalin 2 (Lcn2) was detected at P9
and P20. In addition to its antimicrobial activity, Lcn2 acts as a
marker for abnormal keratinocyte differentiation (18).
K14cre;Dlx3Kin/f skin also exhibited up-regulation of several
members of the kallikrein chymotrypsin-like secreted serine
protease family (Klk5, Klk6, Klk7, and Klk8), which are involved
in skin barrier maintenance (19). Up-regulation of Klk family
members in K14cre;Dlx3Kin/f skin may indicate activation of
pathways involved in barrier function and innate immunity. In-
terestingly, Klk5 and Klk6 expression was up-regulated in PS skin
compared with normal and AD skin (9).
Systems biology analysis identiﬁed a linkage network of cor-
related expression of genes related to barrier function and in-
ﬂammation (20). Many of the genes in this linkage network
(Lce3a, Sprr2i, Sprr2d, K6b, S100a8, Defb3, IL-1F5, IL-1F6,
IL-1F8, and IL-1F9) were differentially expressed in K14cre;
Dlx3Kin/f (Fig. 2A). IL-1F5, IL-1F6, IL-1F8, and IL-1F9 are re-
cently identiﬁed IL-1 family cytokines (21, 22).
Elevated expression of IL-1α, IL-6, and IL-17a was found in
K14cre;Dlx3Kin/f skin (Fig. 2C). IL-1α is a key proinﬂammatory
cytokine secreted by keratinocytes, and both IL-1α and IL-6 play
crucial roles in cutaneous inﬂammation (23, 24). Up-regulation
of IL-17a expression is particularly interesting because IL-17a is
produced by T helper 17 (Th17) cells, a recently identiﬁed subset
of T helper cells that can induce antimicrobial activity and re-
cruit dendritic cells and neutrophils (25, 26). It is well known that
IL-23, a cytokine composed of a unique p19 subunit and the p40
subunit shared with IL-12, promotes the expansion of Th17 cells.
Thus, we examined the expression level of the p19 subunit and
conﬁrmed increased expression (Fig. 2C). Recent studies have
shown that IL-23 or IL-6 can trigger IL-22 production from T
cells, and that IL-22 can mediate the crosstalk between kerati-
nocytes and leukocytes by inducing IL-20 production in kerati-
nocytes (27, 28). Both IL-20 and IL-22 expression were up-
regulated in K14cre;Dlx3Kin/f skin (Fig. 2C). The expression level
of other cytokines, including IL-2, IL-4, IL-5, IL-7, IL-13, IL-15,
and IFN-γ, was not signiﬁcantly changed in K14cre;Dlx3Kin/f skin
(Fig. 2A), suggesting that up-regulation of IL-17 production in
skin may be particularly relevant.
Several chemokines were increased in the skin of K14cre;
Dlx3Kin/f mice (Fig. 2A). Ccl20 and its receptor Ccr6 were
strongly up-regulated (Fig. 2 A and D). A recent study found that
Ccl20 is secreted by keratinocytes, providing the capacity to re-
cruit Ccr6-positive Th17 cells (29). The up-regulation of Ccl20
was corroborated in the results of our microarray analysis (Fig.
2A), qPCR, and immunohistochemistry (Fig. 2D).
IL-17–Expressing T Cells and Leukocytes Are Increased in the Skin of
K14cre;Dlx3Kin/f Mice. To investigate the inﬂammatory response
in K14cre;Dlx3Kin/f mice, we performed immunohistochemistry
with antibodies reactive with CD45 and F4/80 (Fig. 3A). CD45 is
a pan-leukocyte cell surface marker (30), and F4/80 is a marker
for macrophages and epidermal Langerhans cells (21). Cells
expressing these markers were markedly increased from P3 on-
ward in K14cre;Dlx3Kin/f skin (Fig. 3A). The numbers of CD45+
cells and inﬁltrating F4/80+ cells were signiﬁcantly higher in
K14cre;Dlx3Kin/f skin by P3 and remained at increased levels
through P20 (Fig. S3).
Fig. 1. Mice lacking Dlx3 in the epidermis exhibit epidermal barrier defects.
(A) K14cre;Dlx3Kin/fmice at P5 exhibited dry skin near themouthand across the
dorsal skin. (B) Dye-exclusion assays showed barrier dysfunction in E17.5
K14cre;Dlx3Kin/f fetuses. Obvious permeability differences were not detected
at E18.5. (C) Cell envelope preparations from skin of E18.5 fetuses analyzed by
phase contrast microscopy exhibited fragile and sparse cell envelopes in the
K14cre;Dlx3Kin/f skin. (D) Western blot analysis was performed using skin pro-
tein extracts. (E) Expression of Flg, Lor, and claudin 7 was decreased in K14cre;
Dlx3Kin/f mice at P3. Skin samples were obtained fromWT and K14Cre;Dlx3Kin/f
mice (KO) at P1, P3, P5, P9, P15, andP20, and sectionswere stainedwith anti-K6
and anti-PCNA antibodies (green) and DAPI (blue). (Scale bar: 20 μm.)









The frequencies of CD45+ cells and inﬁltrating F4/80+ cells
remained signiﬁcantly higher in K14cre;Dlx3Kin/f skin at 9 wk
(Fig. S4). In addition, systemic inﬂammation was demonstrated
by gross inspection of spleens and lymph nodes at different
stages of postnatal development (Fig. S4). The K14cre;Dlx3Kin/f
mice exhibited progressively enlarged spleens and lymph nodes
compared with those of their WT littermates.
Total leukocytes (CD45+) were isolated from P20 WT and
K14cre;Dlx3Kin/f skin, and these cells were then gated for anti-
gen-presenting cells (APCs), T cells, B cells, Langerhans cells,
and neutrophils (Fig. 3B and Fig. S5A). The fold changes and
total numbers of each of these cell types were increased in
K14cre;Dlx3Kin/f skin, with signiﬁcant increases in neutrophils
and Langerhans cells.
Results from qPCR showedmarkedly increased IL-17 and IL-23
expression in the skin of K14cre;Dlx3Kin/f mice (Fig. 2C). In ad-
dition to Th17 cells, other sources of IL-17, including CD8+ T cells
and γδ T cells, have been reported in skin inﬂammatory responses
(31, 32). To evaluate IL-17a–expressing cells in skin and draining
lymph nodes (DLNs) of WT and K14cre;Dlx3Kin/f mice, we per-
formed analytical ﬂow cytometry for CD4+ T cells, CD8+ T cells,
and γδ T cells and then analyzed intracellular IL-17a expression in
each of these gated cell populations (Fig. 3C and Fig. S5). The
results indicate that IL-17a–producing T cells were increased in
the skin and DLNs of K14cre;Dlx3Kin/f mice. Interestingly, in ad-
dition to Th17 cells, increases in IL-17+ CD8+ T cells and IL-17+
γδ T cells also were detected in both skin and DLNs of K14cre;
Dlx3Kin/f mice. These results are consistent with recent reports
demonstrating that IL-17 can be produced by IL-17+ CD8+ T cells
and γδ T cells, as well as by Th 17 cells (31, 33). The absolute
numbers for each subpopulation are presented in Fig. S5C.
K14cre;Dlx3Kin/f Skin Presents a Gene Expression Signature with
Similarities to Human Inﬂammatory Skin Diseases. To identify pos-
sible similarities between human inﬂammatory skin diseases and
the skin inﬂammation in K14cre;Dlx3Kin/f mice, qPCR analysis
was performed for genes composing signatures for PS and AD (9,
10). These results showed sustained up-regulation of Sprr2d,
Defb3, and S100a9 expression in the K14cre;Dlx3Kin/f mice (Fig.
4A), in agreement with the microarray results (Fig. 2A). Expres-
sion of the Corneodesmosin (Cdsn) gene, located in the PS sus-
ceptibility locus 1 and up-regulated in PS (34), was up-regulated
in K14cre;Dlx3Kin/f skin as well. Thus, K14cre;Dlx3Kin/f mice have
a gene expression signature resembling that seen in PS.
To assess the expression of Dlx3 in human inﬂammatory skin
diseases, we performed immunohistochemistry using Dlx3 anti-
body on sections of PS and AD skin. Dlx3 expression was re-
markably diminished in the PS skin, with no detectable nuclear
localization (Fig. 4B, high-magniﬁcation insets). In contrast,
Dlx3 was readily detectable in most nuclei of the upper differ-
entiated layers of normal and AD skin (Fig. 4B and Fig. S6).
Speciﬁc Contributions of Dlx3-Null Keratinocytes to Inﬂammatory
Mediator Production. We reasoned that Dlx3 deletion in kerati-
nocytes might be linked directly to inﬂammatory mediator pro-
duction. To examine this, we isolated primary keratinocytes from
Dlx3f/f mice and transduced them with adenovirus expressing Cre
recombinase. qPCR analyses revealed increased expression of
IL-1Iα, IL-1F8, S100a9, and Sprr2d in Dlx3-null keratinocytes
(Fig. 5A). These results indicate that ablation of Dlx3 expression
in keratinocytes directly causes altered differentiation and trig-
gers cytokine production that could potentially initiate the inﬂam-
matory responses observed in K14cre;Dlx3Kin/f mice, including the
inﬁltration of leukocytes into skin.
It is well recognized that PPAR expression in the epidermis is
related to epidermal differentiation and inﬂammation (35). We
found decreased expression of PPARα and PPARγ in Dlx3-null
keratinocytes (Fig. 5A). Moreover, both lesional psoriatic and
K14cre;Dlx3Kin/f skin demonstrated increased PPARβ/δ expres-
sion but decreased PPARα and PPARγ expression (36) (Fig. 2A).
To further analyze the effects of PPARγ on Dlx3-null kerati-
nocytes, we transduced Adeno-PPARγ viruses into Adeno-cre;
Dlx3f/f keratinocytes. qPCR analyses showed that the expression
levels of IL-1Iα, IL-1F8, S100a9, and Sprr2d in Dlx3-null kera-
tinocytes reverted to the levels seen in WT control keratinocytes
(Fig. 5B). These results suggest that increased cytokine/chemo-
kine production by Dlx3-null keratinocytes is due, at least in part,
to decreased PPARγ production.
Fig. 2. Gene expression analysis of WT and K14Cre;Dlx3Kin/f
skin by microarray and qPCR. (A) Microarray analysis of total
RNA isolated from skin indicated abnormal terminal differ-
entiation and inﬂammation in K14cre;Dlx3Kin/f mice at P3,
P9, and P20. Numbers indicate fold changes in K14cre;
Dlx3Kin/f skin (KO) vs. WT controls. Aox4, aldehyde oxidase 4;
Ear5, eosinophil-associated, ribonuclease A family member
5; Nkpd1, NTPase, KAP family P-loop domain–containing 1;
Pdzk1ip1, PDZK1-interacting protein 1; Pla2g4e, phospholi-
pase A2, group IVE; Pp11r, placental protein 11-related;
Rptn, Repetin; Slc37a2, solute carrier family 37 (glycerol-3-
phosphate transporter) member 2. (B) Fold changes of KO vs.
WT in the expression of Flg and Lor analyzed by qPCR in P1–
P20 skin. (C) Fold changes of KO vs. WT in the expression of
IL-1a, IL-6, IL-17a, IL-20, IL-22, and IL-23p19 were analyzed by
qPCR in P1–P20 skin, showing up-regulated expression of
cytokines in K14Cre;Dlx3Kin/f skin. (D) qPCR analysis and im-
munohistochemistry for Ccl20 (green) expression in K14cre;
Dlx3Kin/f skin. Sections were counterstained with DAPI (blue).
Ccr6, a receptor for Ccl20, was up-regulated in K14cre;
Dlx3Kin/f skin. n = 3–5 mice per time point. *P < 0.05; **P <
0.005. (Scale bar: 20 μm.)
11568 | www.pnas.org/cgi/doi/10.1073/pnas.1019658108 Hwang et al.
Discussion
Dlx3 Is an Essential Regulator of Epidermal Differentiation. Delayed
acquisition of barrier function was observed in K14cre;Dlx3Kin/f
fetuses. In postnatal mice, gene expression proﬁles of K14cre;
Dlx3Kin/f skin suggest that differentiation defects persist and are
linked to epidermal hyperplasia, accompanied by down-regula-
tion of claudins and transglutaminases and up-regulation of K6
and K16. Altered expression of S100As, β-defensins, and PPAR
genes suggest that abnormal differentiation of epidermis may
lead to inﬂammatory responses associated with the production of
IL-1Fs and IL-17 cytokines. Our ﬁndings of down-regulation of
Pparα and Pparγ in K14cre;Dlx3Kin/f mice and Dlx3-null kerati-
nocytes suggests a possible link between the intrinsic role of Dlx3
as a regulator of epidermal differentiation and inﬂammatory
responses in the skin (36). Based on these ﬁndings, we propose
that Dlx3 is a central and critical regulator of epidermal ho-
meostasis, barrier function, and skin inﬂammation (Fig. 5C).
PS andADare chronic inﬂammatory skin diseases characterized
by epidermal hyperproliferation and abnormal differentiation of
keratinocytes associated with a defective skin barrier. These dis-
eases are prevalent, affecting ∼7–10% of the total population, but
their etiology remains incompletely understood. Characterization
of altered gene expression patterns has provided insights into
the pathophysiology of each disorder (9). In this study, we dem-
onstrated up-regulation of Sprr2d, Defb3, Cdsn, and S100a9 ex-
pression in K14cre;Dlx3Kin/f skin, indicating overlap in gene
expression between this mouse model and the PS gene expression
signature (9, 22). Moreover, marked down-regulation of Dlx3
expression was detected in human psoriatic lesions, suggesting
Fig. 3. Epidermal deletion of Dlx3 triggers inﬁltration of IL-17–producing
and other inﬂammatory cells into the skin of K14cre;Dlx3Kin/f mice. (A) H&E
staining revealed epidermal hyperplasia in K14cre;Dlx3Kin/f skin from P1–P20.
Immunostaining using anti-CD45 and anti-F4/80 antibodies showed in-
ﬁltration of leukocytes, macrophages, and Langerhans cells into K14cre;
Dlx3Kin/f skin. (Scale bar: 50 μm.) (B) FACS analyses were performed to de-
termine fold changes of total CD45+ leukocytes, CD45+CD3ε−MHCII+ APCs,
CD45+CD3ε+MHCII− T cells, CD45+CD3ε−CD19+MHCII+ B cells, CD45+CD3ε−
MHCII+EPCAMhigh Langerhans cells (LC), and CD45+CD3ε−CD11b+Ly-6g+F4/
80− neutrophils in the skin of P20 mice. Error bars indicate SEMs for each
group of four or ﬁve mice. Data are representative of three independent
experiments. Fold changes were calculated by dividing the absolute cell
numbers from each K14cre;Dlx3Kin/f mouse by the average of absolute cell
numbers from WT mice. (C) Fold changes of IL-17a–expressing lymphocytes
in skin and DLNs. Single cell suspensions of dorsal skin were gated on live
CD4+ T cells (TCRβ+TCRγδ−CD4+CD8−), CD8+ T cells (TCRβ+TCRγδ−CD4−CD8+),
and γδT cells (TCRβ−TCRγδ+). Numbers of IL-17a–expressing T cells from P20
K14cre;Dlx3Kin/f mice are expressed as relative fold changes compared with
average cell numbers from WT mice. Error bars indicate SEMs for each group
of four or ﬁve mice. Data are representative of three independent experi-
ments. *P < 0.05; **P < 0.005.
Fig. 4. Gene expression similarity of K14cre;Dlx3Kin/f skin and PS, and histo-
logical analysis of Dlx3 expression in patient samples and normal counterparts.
(A) Signiﬁcant up-regulation of Sprr2d, DefB3, Cdsn, and S100a9was observed
by qPCR analysis in K14cre;Dlx3Kin/f skin from P1–P20. (B) Dlx3 expression was
detected using an anti-Dlx3 antibody (green) and keratin 5 (K5, red) as
a marker for basal keratinocytes. Images include DAPI (blue) counterstaining
to denote nuclear staining (Insets, high magniﬁcation). (Scale bar: 50 μm.)
Fig. 5. Inﬂammatory cytokine production triggered in Dlx3-null keratino-
cytes. (A) Total RNA was isolated from Adeno-cre;Dlx3f/f keratinocytes (KO)
and Adenocre;Dlx3wt/wt (control keratinocytes, WT). Levels of gene expres-
sion were evaluated by qPCR, and fold changes (KO vs. WT) were calculated
for each gene. (B) Adeno-PPARγ viruses were transduced intoWT control and
Dlx3-null keratinocytes. qPCR analyses were performed to assess levels of
expression of each gene. (C) Schematic diagram showing the proposed role of
Dlx3 in epidermal homeostasis, barrier function, and skin inﬂammation. Up-
regulated genes are shown in italic type, and major genes related to barrier
function/inﬂammation are shown in larger type. (*P < 0.05).









that the lack of Dlx3 transcriptional function is potentially in-
volved in the pathophysiology of human inﬂammatory diseases.
IL-17–Mediated Inﬂammatory Responses in K14cre;DlxKin/f Skin. Ex-
pression of multiple IL-1 family members was signiﬁcantly ele-
vated in the skin of K14cre;DlxKin/f mice by P20 (Fig. 2). Previous
studies have demonstrated the critical role of IL-1α, an epider-
mal cytokine, in the maintenance of skin barrier function (37).
The addition of IL-1α to cultured human tumor cell lines was
shown to induce IL-6 and G-CSF production (38). Up-regulation
of IL-6 also was detected in the skin of K14cre;Dlx3Kin/f mice
(Fig. 2). Increased IL-6 secretion might be crucial to under-
standing the IL-17/Th17-dependent inﬂammatory response in
K14cre;Dlx3Kin/f mice, given that IL-6 also promotes the gener-
ation of Th17 cells from naïve T cells (39).
Recent studies indicate that PS is strongly associated with
a Th17-mediated immune response, and inﬁltration of CD8+ T
cells into psoriatic epidermis has been reported (10). The accu-
mulation of IL-17–expressing T cells (including Th17 and CD8+
T cells) was corroborated in both skin and lymph nodes of
K14cre;Dlx3Kin/f mice, in which increased IL-17a expression was
seen as well. A contribution of γδ T cells to skin inﬂammation in
K14cre;Dlx3Kin/f mice was also observed. The possible relevance
of this ﬁnding is supported by the fact that intraepithelial lym-
phocytes bearing γδ TCRs have been identiﬁed as immune
modulators in skin, and that crosstalk between skin γδ T cells and
keratinocytes is known to play an essential role in the mainte-
nance of skin homeostasis (40).
The survival and proliferation of Th17 cells are dependent on
the production of IL-23 (41), and up-regulation of IL-23 was
observed in K14cre;Dlx3Kin/f skin (Fig. 2B). The events and fac-
tors that trigger IL-23 production by either keratinocytes and/or
dendritic cells in the absence of Dlx3 function remain to be elu-
cidated. In addition, strongly increased Ccl20 expression was
detected in K14cre;Dlx3Kin/f skin (Fig. 2). The chemokine Ccl20 is
produced primarily by keratinocytes and acts as a chemoattrac-
tant to stimulate migration of chemokine-receptor Ccr6+ cells
from blood into inﬂamed cutaneous tissue (10, 29). Ccl20 is
particularly relevant for Th17-mediated immune responses, be-
cause Ccr6 is expressed by IL-17–producing cells.
In characterizing our mouse model, we determined that in-
ﬁltration of T cells producing IL-17 was prominent, and that an
intrinsic defect in K14cre;Dlx3Kin/f keratinocytes was associated
with the development of an IL-17–mediated inﬂammatory re-
sponse. The degree to which perturbation of barrier function
contributes to the subsequent inﬂammatory response remains to
be determined.
K14cre;Dlx3Kin/f Mice as a Mouse Model for Human Inﬂammatory Skin
Disease. Although inﬂammatory skin disorders are often accom-
panied by decreased barrier function, the role of this barrier
dysfunction in disease causality is often unclear. Most notably,
inﬂamed skin generally exhibits abnormal keratinocyte differ-
entiation, disrupted barrier function, and/or immunocyte ab-
normalities (9–11). Mouse models have been critical tools in
examining some of these complex interactions (42, 43). Targeted
epidermal deletion of such genes as JunD, Klf4, Gata3, and
Notch in mice results in defects in barrier formation due to ab-
normal skin differentiation (44–47), and many barrier dysfunc-
tion models exhibit aspects of AD and PS (42, 43). Numerous
mouse models have been generated in the hope of elucidating
the pathogenesis of human PS (42). However, human skin differs
from mouse skin in terms of thickness, width of interfollicular
regions, and epidermal turnover, and a complete psoriasiform
phenotype is not readily observed in mice.
In this study, we characterized gene expression proﬁles and
cutaneous inﬂammation in K14cre;Dlx3Kin/f mice and in Dlx3-
null keratinocytes cultured in vitro. These proﬁles revealed al-
tered keratinocyte differentiation and up-regulated cytokine and
down-regulated PPAR expression. These ﬁndings suggest that
certain aspects of the inﬂammatory responses observed in
K14cre;Dlx3Kin/f mice, including the inﬁltration of leukocytes
into skin, are keratinocyte-initiated and are mediated in part by
a PPAR-regulated mechanism.
In summary, we have described a mouse model with epidermal
deletion of Dlx3 that can be used to deﬁne the contributing role
of keratinocytes to the pathogenesis of cutaneous inﬂammation
that may be relevant to one or more human skin diseases. This
model should allow detailed and systematic exploration of im-
portant relationships between keratinocyte and recruited immu-
nocytes in inﬂammatory responses.
Materials and Methods
Mice. Mouse strains Dlx3Kin/+ (LacZ knock-in heterozygote), Dlx3f/f (ﬂoxed
homozygote), and K14cre;Dlx3Kin/fwere generated and genotyped as re-
ported previously (14). All animal care and experimental protocols were
approved by the National Institute of Arthritis and Musculoskeletal and Skin
Diseases Animal Care and Use Committee.
Human Skin Samples. Skin biopsy specimens were obtained from patients and
normal adults after provision of written informed consent. All procedures
received previous approval from Yonsei University College of Medicine’s
Institutional Review Board in accordance with the Declaration of Helsinki.
Skin Barrier Function Analysis and Preparation of CEs. Dye permeability assays
were performed with 1% hematoxylin (EMD Chemicals) for 1 h at 30 °C (15).
CEs were prepared from skin samples as described previously (13). Isolated
CEs were analyzed by phase-contrast microscopy (Axiophot; Zeiss).
Western Blot Analysis. Protein samples from dorsal skin of mice were sub-
jected to Western blot analysis. The following antibodies and dilutions were
used: anti-Flg (1:1,000; Covance), anti-Lor (1:1,000; Covance), anti-Claudin 7
(1:500; Invitrogen), anti-actin (1:1,000; Sigma-Aldrich), and horseradish per-
oxidase-conjugated secondary antibody (Vector Laboratories).
Histology, Immunoﬂuorescence, and Confocal Microscopy. Skin sections (10 μm
thick) were stained with H&E or used for immunohistochemistry after in-
cubation with primary antibodies (14): anti-Dlx3 (1:250; Morasso Labora-
tory), anti-K6 (1:100; Covance), anti-PCNA (1:100; Calbiochem), anti-CD45
(1:50; BD Bioscience), anti-F4/80 (1:50; AbD Serotec), anti-K5 (1:50; Lifespan
Biosciences), and anti-Ccl20 (1:50; R&D Systems) and secondary antibodies
Alexa Fluor 488 or Alexa Fluor 546 goat IgG (1:250; Molecular Probes).
RNA Isolation, Microarray Analysis, and qPCR. Total RNA was prepared from
the dorsal skin of mice or cultured keratinocytes using the RNeasy Mini Kit
(Qiagen) according to the manufacturer’s instructions, and quantity and
quality were evaluated by RNA capillary electrophoresis (Agilent). RNA was
reverse-transcribed into cDNA using the ImProm-II Reverse-Transcription
System (Promega). Microarray analysis and data processing were performed
at the National Institute of Diabetes and Digestive and Kidney Diseases
Genomics Core Facility using an ABI Prism 7900HT Sequence Detection Sys-
tem (Applied Biosystems) (48). qPCR analysis was done in triplicate using the
MyiQ Single-Color Real-Time PCR Detection System (Bio-Rad) and iQ SYBR
Green Supermix (Bio-Rad). The following primers for qPCR were purchased
from Qiagen or synthesized according to previous reports: Ccl20 (QT02326394),
Ccr6 (QT 02256002), Cdsn (QT00287217), DefB3 (QT00265517), GAPDH
(QT01658692), IL-1a (QT00113505), IL-1F8 (QT01067045), IL-6 (QT00098875),
IL-17a (QT00103278), K10 (QT01748397), Pparα (QT00137984), Pparγ
(QT00100296), S100a9 (QT00105252), Sprr2d (QT00133931), IL-23p19 (49),
and RPLP0 (50). The primers for Dlx3 as follows: forward, ATTA-
CAGCGCTCCTCAGCAT; reverse, CTTCCGGCTCCTCTTTCAC. Relative expression
was normalized against the housekeeping genes RPLP0 and GAPDH. Fold
changes were calculated by the Ct method (51).
Microarray and qPCR analyses were performed for each groupwith at least
three WT and three mutant mice at each developmental stage: P1, P3, P5, P9,
P15, and P20 in this study.
Flow Cytometry. Dorsal skin (2 cm × 3 cm) was incubated for 1 h, 45 min at
37 °C with 5 mL of RPMI medium containing 500 μg/mL of Liberase CI (Roche)
and then minced with sharp scissors. Single-cell suspensions were prepared
after an additional 15 min incubation with 0.05% DNase I (Sigma-Aldrich),
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followed by sequential ﬁltering through 100-, 70-, and 40-μm nylon mesh.
Lymph node (inguinal, axillary, and brachial) capsules were torn with sharp
forceps, and tissues were incubated for 30 min at 37 °C in 2 mL of RPMI
medium containing 100 μg/mL of Liberase CI (Roche). Lymph node cell sus-
pensions were prepared by vigorous trituration and ﬁltered through 40-μm
nylon mesh. For T cell intracellular cytokine staining, cells were stimulated
with 50 ng/mL of phorbol myristate acetate and 500 ng/mL of ionomycin
(Sigma-Aldrich) in the presence of brefeldin A and monensin (eBioscience)
for 4 h before surface staining with antibodies. Isolated cells were stained in
PBS, 2% FCS, 1 mM EDTA, and 0.01% NaN3 with the following antibodies in
the presence of Fc blocking antibodies: anti–CD4-Paciﬁc Blue (RM4-5), anti–
CD8-APC-eFluor780 (53-6.7), anti–TCRβ-PE (H57-597), anti–TCRγδ-PerCP-
eFluor710 (GL3), anti–CD45-eFluor450 (30-F11), anti–CD11b-eFluor605NC
(M1/70), anti–Ly-6G-PE-Cy5 (RB6-8C5), anti–CD3e PerCP-eFluor710 (17A2),
anti–EPCAM-PE-Cy7 (G8.8), anti–IL-17a-AF488 (eBio17B7), and anti–IFN-γ-APC
(XMG1.2). All antibodies were purchased from eBioscience except anti–F4/
80-AF700 (CI:A3-1, Abd Serotec). Lower limit thresholds were set using iso-
type control mAb. Data were acquired on a LSR II ﬂow cytometer (BD), and
analysis was performed with Flowjo Software 7.5 (Treestar).
Four or ﬁve WT and mutant mice were used for each experiment, and
results presented are representative of three independent experiments.
Dlx3 Deletion in Cultured Keratinocytes by adenoCre Transduction. Primary
keratinocytes were isolated from Dlx3f/f mice, and CD1 cells were transduced
with adenovirus expressing Cre-recombinase and/or PPARγ (Vector Biolabs) at
5MOI in infectionmedia (S-MEMwith 4 μg/mLof polybreneand0.05mMCa2+)
for 30 min. The cells were subsequently cultured in low-calciummedium (10%
chelated FCS, 0.05 mM Ca2+) for 72 h and lysed in TRIzol (Invitrogen).
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